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Simulationen, Optimierungen und mikrodosimetrische
Messungen der Strahlqualität für die
Schwerionen-Krebstherapie
Krebstherapie mit Teilchenstrahlen bietet die Möglichkeit, den Tumor noch geziel-
ter zu treffen als mit Röntgenstrahlen, wodurch umliegendes, gesundes Gewebe bes-
ser geschont wird und so die Erfolgswahrscheinlichkeit der Therapie erhöht werden
kann. Die Anwendung dieser Technik bedarf allerdings weitreichender Kenntnisse
nicht nur über die physikalischen Aspekte, sondern auch über die biologische Wirk-
samkeit der Strahlung in Gewebe. Diese Wirksamkeit hängt kompliziert von vielen
physikalischen wie auch biologischen Faktoren ab und muss mit komplexen Modellen
berechnet werden; es gibt jedoch einen engeren Zusammenhang mit dem linearen
Energietransfer (LET), also dem Maß für die Konzentration der Energieabgabe ei-
nes Teilchens entlang seiner Spur: steigt der LET (bis zu einer gewissen Schwelle),
so steigt auch die biologische Wirksamkeit. Ferner können wegen Sauerstoffarmut
strahlenresistente Tumorzellen ebenfalls mit einem hohen LET wirksam abgetötet
werden. Der LET selbst hängt jedoch wiederum von der kinetischen Energie des
Teilchens ab, genau wie die Strahlendosis. Dies macht eine simultane Optimierung
beider Größen nur bedingt möglich, eine Methode wird jedoch in dieser Arbeit vorge-
stellt, die sich das Konzept der Dosisrampen zunutze macht. Es werden Beispiele für
Teilchenstrahlung bestehend aus Protonen, Kohlenstoffionen oder Antiprotonen vor-
gestellt und gezeigt, dass sich mit den heute verfügbaren und zugelassenen Mitteln
der klinischen Dosisplanung Bereiche mit hohem LET vorteilhaft im Tumorvolumen
verteilen lassen, ohne die Dosisverteilung nennenswert zu beeinflussen.
Im experimentellen Teil der Arbeit geht es um die Anwendung eines gewebeäquiva-
lenten Proportionalzählers (engl. tissue-equivalent proportional counter, TEPC), um
mikroskopische Dosisverteilungen in linealer Energie, d. h. die Fluktuationen in der
Energiekonzentration in subzellulären Größenordnungen, zu bestimmen. Das Maß
der Fluktuationen und die Höhe der Energiekonzentration stehen ebenfalls, wie der
LET, mit der biologischenWirksamkeit in Zusammenhang. In den vorgestellten Mes-
sungen wird überprüft, ob sich zwei gängige Varianten der Teilchenstrahlapplikation
maßgeblich in ihren Dosisverteilungen in linealer Energie unterscheiden, sodass sich
unter Umständen aus den Unterschieden ein unterschiedlicher biologischer Effekt
ableiten lässt.
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Simulations, Optimizations, and Microdosimetric
Measurements of Beam Quality for Heavy-Ion Tumor
Therapy
Tumor radiotherapy with charged particles offers superior properties in covering
the tumor with radiation dose, while sparing the surrounding, healthy tissue better
than standard X-rays. Thus, the success of the therapy is potentially increased.
However, the application of this technique necessitates not only profound knowledge
about its physical aspects, such as the uncertainties in the range of the particles
which need to be taken into account in the therapy planning stage. In addition
to the physical aspects, the biological effectiveness of particle radiation needs to
be thoroughly understood. The effectiveness depends on many physical as well as
biological quantities and is determined involving complicated models. Though, there
is a close relation with the linear energy transfer (LET), i. e. the measure of the local
concentration of energy deposition along a particle’s track. The higher the LET (up
to a certain limit), the higher the biological effect. Furthermore, radiation resistant
cells, e. g. due to a lack of oxygenation, can be effectively killed with radiation that
has a high LET. The LET itself depends on the kinetic energy of the particle, just
like the dose, which makes a simultaneous optimization of dose and LET possible
only under some circumstances. However, this work presents a method that makes
use of the dose ramp concept to beneficially re-distribute areas with high LET using
protons, carbon ions and antiprotons, respectively, without notably influencing the
dose distribution.
In the experimental part of this work, a tissue-equivalent proportional counter
(TEPC) is used to measure microscopic dose distributions in lineal energy, i. e.
fluctuations of the energy concentration on sub-cellular length scales. The extent of
these fluctuations as well as the magnitude of the energy concentration have, like
the LET, an influence on the biological effect. In the measurements presented here
it is assessed if there is a significant change in the dose distributions in lineal energy
when comparing two methods of particle beam application to determine a potential
impact on the biological effect.
2
1 Radiation Cancer Therapy
The uncontrolled growth of tissue is called cancer, i. e. malignant neoplasm. It is one
of the most frequent causes of death, e. g. 25% of all deaths in Germany were due to
cancer in 2010 [1]. Remarkably, in 2008, about 54% of all diagnosed cancers have
been cured in Germany [2]. Neoplasms can be divided into benign tumors that are
growing only slowly and threaten the organism mainly by their space consumption,
while malignant tumors infiltrate neighboring tissue and can spread into the whole
organism by the lymphatic and blood system. Further sub-divisions and information
can be found in [3] (English) and [4] (German).
Tumors can be treated by means of surgery, medication (chemotherapy), and ra-
diation therapy (external or internal), with the treatment chosen according to the
tumor type, stage, and grade. Benign tumors are often treated by a combination
of surgery and radiation therapy, while the therapy of malignant tumors most often
includes chemotherapy because of its ability to metastatize into the whole organism.
Radiation therapy is defined as the treatment of malignant tissue with ionizing
radiation. Other methods using non-ionizing irradiation are e.g. microwave or heat,
light, ultra sound, and UV therapy. Ionizing radiation can be applied by means
of teletherapy, where the radiation source is outside the body of the patient or by
implanting radiation sources into or situating them very close to the target tissue
(brachytherapy). Some more basic information about cancer and its therapy is given
in this chapter.
1.1 Cancer treatment with ionizing radiation
Only two years after their discovery byW.C. Röntgen in 1895, X-rays have been used
to irradiate tumors. Later, also neutrons, electrons, gamma rays from 60Co, X-rays
from electron bremsstrahlung, pions, protons and heavier ions were successfully
3
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introduced. Today, the largest fraction of patients (about 1 million in the USA
in 2004 [5]) is treated with X-rays resulting from bremsstrahlung of electrons with
kinetic energies in the range between 6 and 23MeV. Less than 1% of the patients
elegible for radiation therapy receive particle beam treatment (between 2012 and
2013, 5761 patients were treated with protons in the USA)1 at least as part of their
therapy.
The most prominent physical difference of the various irradiation techniques is the
depth-dose distribution, i. e. the deposition pattern of energy to unit masses of the
surrounding matter in dependence of the penetration depth. While photons show,
after a build-up region of several millimeters, an exponential decay of deposited
energy, charged particles deposit little energy as long as their kinetic energy is high,
and a large amount at the end of their range, resulting in the so-called Bragg peak
(cf. fig. 1.2). The average energy loss of a charged particle per unit path length
traveled depends on the particle’s kinetic energy and is also a property of the material
traversed. It is called stopping power (SP) and can be expressed as a sum of three
physical processes: The collision stopping power, which is the energy lost in inelastic
collisions with the target’s electrons, radiative losses due to bremsstrahlung, and the
energy transferred to target nuclei in elastic collisions:
SP = −
[(
dE
dx
)
col
+
(
dE
dx
)
brems
+
(
dE
dx
)
nuc
]
(1.1)
The collision stopping power is the dominant one for charged particles heavier than
electrons and has first been described by Bethe [7]. The second term is only relevant
for electrons that lose a considerable amount of their energy by bremsstrahlung. Be-
cause the bremsstrahlung cross section depends on the inverse square of the projec-
tile’s mass, it becomes irrelevant for protons or heavier ions. The last term becomes
significant only for very low projectile energies (it is larger than 1% only for protons
with less than 20 keV energy in water, cf. [8]).
The formula for the collision stopping power, including the extension for slow as
well as highly relativistic particles is given in eq. 1.2.
1the number was calculated from the yearly patient number statistics published by the Particle
Therapy Cooperative Group, PTCOG, taking only proton therapy centers in the USA into
account [6].
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SPcol = −
(
dE
dx
)
col
=
4pinz2eff
mec2β2
·
(
e2
4piε0
)2
·
[
ln
(
2mec2β2
I(1− β2)
)
− β2 − C
Z
− δ2
]
(1.2)
SP, the stopping power, is the mean loss of energy dE of a particle on a length dx
traveled. n = Z·ρ
A·u is the electron density (Z and A being charge and mass number
of the target nuclei, ρ the density and u the atomic mass unit), mec2 the electron
rest energy, zeff the effective charge and β = v/c the velocity of the beam particle.
The effective charge can be described with the Barkas formula and differs from the
atomic number only for small velocities. e is the charge constant, ε0 the vacuum
perittivity. I in the logarithmic term represents the mean ionization potential of the
target, which is either measured and tabulated or often roughly approximated by
I = 10 eV · Z. C and δ are the shell and density correction, respectively. While the
shell correction only accounts for corrections for very low kinetic energies, where the
projectile velocity is in the order of or lower than the target electron velocity, the
density correction includes the dielectric polarization of dense media and becomes
relevant for kinetic energies much larger than the therapeutic range. More informa-
tion as well as tabulated values for the stopping power in the therapeutic energy
range can be found in ICRU Report 49 [8] for protons and alpha particles and in
ICRU Report 73 [9] for particles heavier than helium, respectively.
As the particle range depends on the particle’s initial energy, many pristine Bragg
peaks with different depths are superimposed to achieve a constant high dose through-
out the tumor’s depth. This is called spread-out Bragg peak (SOBP) and its con-
struction with pristine peaks is shown in fig. 1.1.
Calculated examples of depth-dose distribution for protons and carbon ions in com-
parison with photons can be seen in fig. 1.2. The stong decrease of energy deposition
after the Bragg peak and the higher dose in the target region compared to the dose
in front make particles excellent candidates for a better dose conformation to the
tumor than photons and, therefore, a better treatment outcome. For heavier ions,
this effect is further enhanced in the lateral direction, i. e. perpendicular to the beam
axis, because of reduced angular scattering.
In addition to these purely physical advantages, the biological effect of the same
physical dose may be different for different types of radiation. This issue is discussed
in more detail in the next section.
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Figure 1.1: Construction of a spread-out Bragg peak (SOBP). Image adapted
from [10].
1.2 Biological effect of ionizing radiation
Radiation therapy aims to introduce irreparable lesions to the DNA of cancer cells.
These changes are supposed to prevent the cell from further proliferation or to
trigger its apoptosis, i. e. its suicide program. Fitting the fraction of cells surviving
irradiation of different levels of dose, in-vitro as well as in-vivo experiments show a
relation between the absorbed dose, D, and the cell survival, S, that can be described
by a linear-quadratic (LQ) exponential function [11]:
S = exp
[
−
(
αD + βD2
)]
(1.3)
Beyond its property of being just a reasonable fit to survival data, the ratio of
the coefficients can be related to some radiological meaning: as α is the coefficient
for the initial slope at small doses and β the coefficient for the curvature at larger
doses, α/β describes the degree of response of the irradiated tissue. Large α/β ratios
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Figure 1.2: Depth-dose curves of 6MV photons, a proton and a carbon ion spread-
out Bragg peak (SOBP). Compared to the photon dose profile (red solid curve),
the particle dose profiles (green dashed line for protons, blue dots for carbon ions)
are inverted. The small amount of dose after the carbon ion peak is due to lighter
particles generated in inelastic collisions which have a longer range. The biological
effect of carbon ions is enhanced, particularly in the SOBP, and not shown here.
correspond to so-called “early” or “acute” reacting tissues, of which most tumors are
part of, whereas small ratios correspond to late reacting tissues, which fortunately
turns out to be the case for most healthy tissues. Consequently, a fractionation
of the total dose, i. e. multiple irradiations with small doses during a longer time
period, is often beneficial to save healthy tissue.
As mentioned, it has turned out that cells react differently to various types of ir-
radiation, such that even if the physical dose D is the same, the survival S can be
different. To compare the biological effect of various types of irradiation, the con-
cept of relative biological effectiveness (RBE) has been introduced. It is the ratio
of the physical dose of a reference radiation, generally 60Co gamma rays, to a test
7
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radiation achieving the same biological effect (e. g. survival fraction S):
RBE = D60Co
Dx
∣∣∣∣
iso-effect
(1.4)
Despite its rather simplistic definition as the above mentioned ratio, the RBE de-
pends on many physical and biological parameters: dose, dose per treatment frac-
tion, radiation quality (e. g. linear energy transfer, LET, definition in sec. 2.1.1),
desired biological endpoint, cell type, the damage repair abilities of a cell, and many
more. The dependence on LET will be described in more detail in sec. 2.1.2.
The planning of a cancer treatment aims to optimize for an optimal dose level in
the target volume containing the tumor, and an as low as reasonably achievable
level of dose in the surrounding healthy tissue. For treatment planning involving
charged particles heavier than protons2, this also includes the determination of the
RBE throughout the irradiated volume, which is, as indicated above, not easily ac-
cessible. Therefore, models have been developed to estimate the RBE from physical,
measureable, quantities. An implementation of the Local Effect Model (LEM) [13]
is successfully used in determining the biologically effective dose in treatment plan-
ning at the Heidelberg Ion Beam Therapy Center (HIT). Japanese research groups
use the Microdosimetric Kinetic Model (MKM) to calculate the RBE from quan-
tities measured by microdosimetric equipment [14]. Both models assume that the
biological effect depends solely on the energy deposited in small compartements of
the cell, which is depending on the track structure of the radiation. The MKM is
explained in more detail in chapter 3.
1.3 Present status and challenges in radiation therapy
The beneficial outcome of cancer therapy depends on the success of every link in the
chain of steps involved, starting from tumor identification and localization (imaging),
dose planning, patient positioning and the actual patient treatment.
The precision achievable with particle beam therapy can only be fully exploited when
a precise knowledge of the target volume can be obtained. The imaging modality
2Even for protons some researchers argue that it may be necessary to take the varying RBE into
account, especially if irradiation concepts like distal edge tracking are employed [12].
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typically used for treatment planning is computed tomography (CT) because of the
very good spatial resolution (1mm and less) compared to other methods. However,
the patient is exposed to additional dose as the modality uses X-rays. Furthermore,
the soft tissue contrast is not high enough to resolve small tumor infiltrations into
healthy tissue. Functional imaging like positron emission tomography (PET) and
magnetic resonance imaging (MRI) can provide additional information about the
tumor, like its metabolic activity or better information about the tissue composition.
The aspects of imaging are discussed in more detail in [15].
One of the main challenges of using CT imaging in particle therapy is the uncertainty
in converting the measured electron densities into water equivalent path lengths of
charged particles needed to calculate their range. As a significant amount of dose
is deposited in the Bragg peak at the end of the particle range, this very position
has to be known as precisely as possible. The maximum error resulting from this
density conversion is about 3% [16]. To make sure that the whole tumor volume is
covered with a high dose, the margins of the tumor volume are increased such that a
too low range resulting from these uncertainties does not result in an underdosage.
For X-ray therapy, this is not an issue because of the smooth decline in deposited
energy along the depth (cf. fig. 1.2). To overcome the uncertainties involving X-ray
CT conversion, research has been initiated to replace the X-rays by high-energy
particles from the same facility that is also carrying out the treatment. The particles
are energetic enough to exit the patient and a measurement of their residual energy
allows a density reconstruction along the particle track [17, 18]. Several groups aim
to image the Bragg peak position during the treatment by means of prompt-gamma
or secondary charged-particle emission [19, 20, 21]. It was also shown that in the
case of antiproton irradiation, the charged pions created in annihilation reactions
can be used to reconstruct the Bragg peak position, in principle with an accuracy
in the order of 1mm [22]. The only method used successfully in a clinical routine
environment is to take PET images after an irradiation fraction as the particle beam
generates β+ emitters (11C, 15O, 13N, and 38K) in the traversed tissue. In the case
of carbon ions as beam particles, they become β+ emitters (11C, 10C) themselves
by inelastic nuclear scatterings along their trajectories. The areas with high PET
activity can then be related to the range of the primary particles [23, 24]. Especially
for protons, the activity pattern is however significantly different from the dose
pattern, as activity is only generated when the protons have high enough energies
to produce β+ emitters in inelastic reactions. The situation is further complicated
9
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if the imaging is performed after instead of during the treatment in order not to
block the treatment facility, as the data acquisition time is in the order of tens of
minutes. In this case, a large portion of the emitters has already decayed and the
β+ emitter distribution is distorted because of biological transport [25]. A detailed
review about in-vivo proton range verification techniques is given in [26].
Also, the treatment planning is advancing due to new possibilities of functional
imaging. The tumor is known not to consist of homogeneous tissue only, but shows
different compartments that respond differently to radiation. For example, there can
be subvolumes that are not well oxygenated because they are too far away from a
blood vessel, the so-called hypoxic areas, and they express a very low radiosensitivity,
i. e. a higher dose is needed to reach the same effect as for normoxic cells. This is
because oxygen is an important component in the chain of free radical reactions
created instantly after irradiation and, therefore, plays an important role in the
biological effectiveness. Even though studies have shown that imaging of hypoxic
areas is possible with special PET markers ([27] gives a good overview), the problem
remains that the hypoxic regions can change over time. Nevertheless, tumor hypoxia
and the need for additional dose in hypoxic volumes has been included in the GSI
(Gesellschaft für Schwerionenforschung) research treatment planning application.
Furthermore, it has been shown that hypoxic areas can be treated more effectively
if the LET of the radiation in these areas is high [28, 29], as it will become more
clear in chapter 2. In principle, it is also possible to optimize for a homogeneous
dose and an arbitrary LET distribution within the tumor by means of a concept
called LET painting [30, 31].
10
2 Linear Energy Transfer and its
Optimization
This chapter deals with fundamental properties of the linear energy transfer (LET),
its applications in radiation therapy planning and the different optimization tech-
niques. In the scope of this work, the dose-averaged LET is optimized to cover the
whole target volume with the maximum possible LET value while maintaining a flat
dose profile. The technique can be extended to target specific subvolumes in the
treatment volume identified as hypoxic, e. g. by functional PET imaging.
2.1 Basic properties of LET
2.1.1 Definition and averages of LET
The development of quantities describing the radiation quality started in the 1940s,
when primary ionization densities were considered [32]. A more detailed overview
of the history is disscussed in the corresponding ICRU Report [33]. The definition
of LET is
LET∆ =
(
dE
dl
)
∆
. (2.1)
It “is the quotient of dE by dl, where dl is the distance traversed by the particle and
dE is the mean energy-loss due to collisions with energy transfers less than some
specified value Δ.” [33] Thus, the LET is closely related to the electronic stopping
power (cf. sec. 1.1). In fact, it is also called restricted stopping power, because of the
cut-off value Δ. The reason to introduce such a threshold is to have a measure of
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the energy deposited locally, in the vicinity of the primary particle track, as it is this
local energy deposition that has a strong influence on the biological effect. Higher
energy deposits may result in ionization electrons that have high enough energies
to travel a certain distance, thus carrying away energy to more distant regions
irrelevant for the local biological effect. Δ usually has the unit eV; the unrestricted
LET, is commonly noted as LET∞ (the maximum energy transfer, however, is not
infinitely large, but given by kinematics) and is, identical to the negative stopping
power dEdx = −SP . Secondary particles with energies exceeding the cut-off value are
treated as separate particles.
The LET with a certain threshold Δ is obtained by integrating the underlying
formula yielding eq. 1.2 only to energy transfers up to Δ, instead of all possible
energy transfers, which results in [33]
LET∆ = −
(
dE
dx
)
∆
=
2pinz2eff
mec2β2
·
(
e2
4piε0
)2
·
[
ln
(
2mec2β2∆
I2(1− β2)
)
− (1− β2)∆2mec2 − β
2 − 2C
Z
− δ
]
. (2.2)
To relate the LET to treatment scenarios, where many, possibly different, primary
beam particles with different energies and angles impinge a target volume, and addi-
tionally, the number of secondary particles along a primary particle’s track increases
because of inelastic reactions, the distribution of LET is commonly expressed in two
averages:
• Track- or fluence-averaged LET: integral form as defined in ICRU Report 16 [33]:
LET t =
∞ˆ
0
t(LET )LET dLET (2.3)
t(LET) is the track length distribution of particles with the linear energy
transfer LET, it is weighted by the LET and integrated over all possible values
of LET.
12
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The discrete form is needed for computational purposes:
LET t =
∑
z
∑
E LET (E; z) Φ(E; z)∑
z
∑
E Φ(E; z)
(2.4)
here, the LET of every particle species z and every occuring energy E is
weighted by its fluence Φ, i. e. the number of particles dN incident on a sphere
with the cross-sectional area dA, having that particular species and energy,
and the sum is normalized by the total fluence.
• Dose-averaged LET:
LET d =
∞ˆ
0
d(LET )LET dLET (2.5)
Compared to the track averaged LET, the weighting is done here by the dose
instead of the fluence.
Its discrete form is:
LETd =
∑
z
∑
E LET
2(E; z) Φ(E; z)∑
z
∑
E LET (E; z) Φ(E; z)
=
∑
z
∑
E LET (E; z)D(E; z)
Dtotal
(2.6)
There is discussion in the scientific community about which of the averages is more
related to a biological effect, some researchers even doubt the concept of LET in
general, because it is a quantity averaged over energy deposits with a very wide
range. Microdosimetry tries to overcome this problem and provides measurements
of spectra of locally deposited energy in small volumes, considering this wide range
of possible energy deposits. More details are discussed in chapter 3. However, it
seems that there is a significant correlation between LET and the relative biolgical
effectiveness (RBE), as will be discussed in the next section.
2.1.2 Influence of LET on RBE
As pointed out in sec. 1.2, the RBE is defined as the ratio of two doses of different
radiation type resulting in identical biological effects and depends on many physical
and biological quantities. Sørensen et al. [34] compared data reported on the RBE
for different types of radiation. It turns out that in spite of the complexity of the
13
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RBE concept, there is a significant correlation between the dose-averaged LET and
the relative biological effectiveness, cf. fig. 2.1.1
Figure 2.1: LET-RBE relation for V79 cells for different ions. Taken with permis-
sion from [34].
2.1.3 Influence of LET on OER
As pointed out in sec. 1.2, cells react differently to the same amount of dose but
different radiation quality. In particular, there is a relation between the oxygenation
of a cell and its radiosensitivity. If cells are provided with little or no oxygen, more
dose is needed to kill them. The ratio of the dose needed to achieve a certain survival
fraction S in a hypoxic situation and the dose needed at normal oxygenation is called
oxygen enhancement ratio (OER):
OER = Dhypoxic
Dnormoxic
∣∣∣∣
iso-effect
. (2.7)
1The authors of the cited publication do not explicitely name the average, but only refer to “LET”.
However, in the vast majority of the data sources they have collected, the dose-averaged LET
was applied.
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Wenzl et al. [35] review the LET-OER relationship measured by different experi-
ments and conclude that there is a relation between LET and OER (fig. 2.2), and
within the errorbars, the dependence on different particle types or cell lines is small.
However, there is a significant difference in the LET-OER relationship reported for
in-vitro and in-vivo situations, where the latter shows generally lower OER values.
Figure 2.2: LET-OER relationship. Figure taken from [35]. Error bars from origi-
nal publications, if provided. Different colors for different cell lines. Open circles:
in-vivo data, filled circles: in-vitro data. Dashed and solid line: OER calculated
from model presented in the publication.
2.1.4 Measurement of LET
Direct LET measurement devices do currently not exist. The main problem arises
from the fact that a LET detector has to incorporate the cutoff-value Δ, in order to
not include energetic secondary particles. Furthermore, the gradients of dose and
LET distributions along the track of charged particles are high, especially at the
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Bragg peak, which makes a high spatial resolution necessary. However, a promising
approach is to use the effect of recombination, i. e. the “missing signal” due to signal
quenching when using an ionization chamber where the active volume is a liquid
in comparison with a signal from a regular air-filled ionization chamber. Together
with data generated by Monte-Carlo simulations the LET can be assessed. For more
information cf. [36].
Another approach is the usage of passive nuclear track detectors, such as the plastic-
based track-etch detectors (CR-39) [37, 38, 39], or fluorescent nuclear track detectors
(FNTD) [40], where the impact of the primary ions as well as the generated sec-
ondary particles can be made visible and the deposited energy assessed. However,
compared to the technique previously described, a real-time measurement of the
LET is not possible.
2.2 Dose and LET planning and optimization
2.2.1 Planning
Dose planning is one of the critical links in the chain of cancer treatment (cf. sec. 1.3).
It is done after the tumor has been localized and delineated by a physician. Gener-
ally, the treatment plan consists of several volumes, making up the tumor volume
itself and several extensions of that volume. Such volume extensions are described
in a dedicated ICRU Report [41] and take all known uncertainties into account,
e. g. the invisible infiltration of the tumor into the surrounding tissue, positioning
uncertainties, and residual tumor motion. Furthermore, critical organs nearby that
have low tolerance doses are included as constraints. It is a balancing act between
assuring that the tumor is completely covered with the dose needed to kill it and
to spare the healthy surrounding tissue from unnecessary dose. The optimal dose
distribution is often obtained when multiple irradiations from different angles, the
so-called fields, are optimized and irradiated. By this method, the tumor is al-
ways hit by radiation, but the unavoidable dose to the surrounding healthy tissue
is spread over larger volumes. In intensity modulated radiotherapy (IMRT) using
photons, usually 6–8 fields are applied, whereas due to the better intrinsic dose pro-
file of particles, but also due to technical constraints (e. g. treatment time, gantries
not universally available, etc.) the number of fields in particle therapy typically
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is 1–3. Two opposing directions are often used to mitigate problems due to range
uncertainties.
2.2.2 Optimization
Modern radiotherapy techniques like IMRT or volumetric modulated arc therapy
(VMAT) for photon irradiation, or actively delivered particle therapy offer many
degrees of freedom for performing the actual treatment. To achieve an optimal dose
coverage across the tumor volume while minimizing the dose to the surrounding tis-
sue and especially critical organs, computer software has been developed to optimize
the technical parameters for each individual tumor. In some cases, the optimiza-
tion is repeated if the tumor or the patient anatomy has changed in the course
of the treatment. Different optimization techniques exist; usually they are based
on the inverse planning method, i. e. finding the optimal parameters to achieve a
predescribed dose distribution. In the particular case described in this work, the
treatment is carried out by scanning a thin pencil beam of particles across the tar-
get volume. As a consequence, the typical combination of different beam positions,
widths, energies, and fluences needed to cover a tumor volume with the desired dose
accounts for many thousands of degrees of freedom. The underlying optimization
routine minimizes the difference between the prescribed dose distribution and the
dose distribution generated by a combination of fluences Φ of particles for each
position x, energy and beam width:
χ2 =
∑
w(x) (Dprescribed −D(x))2
∂χ2
∂Φ = 0 (2.8)
w(x) is a weighting factor, the prescribed dose is a constant in eq. 2.8, but can in prin-
ciple be an arbitrary dose distribution, e. g. a linear function as applied in sec. 2.3.
For particles with varying RBE along their path, the biological dose is calculated in
each iteration of the optimization process, such that the treatment plan can also be
optimized for a homogeneous biological dose across the target volume. Furthermore,
the quantity to minimize can be extended by constraints, e. g. including maximal
tolerable doses to nearby organs at risk. A full overview of the algorithms and
their implementation into the research treatment planning system TRiP (treatment
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planning for particles) developed at GSI is given in [42, 43, 44]. Newer developments
include the oxygenation status of the target and the dependence of hypoxia on LET
into the planning, resulting in an inhomogeneous dose distribution to achieve a
homogeneous biological effect [45]. Procedures like this are commonly called dose
painting.
2.2.3 Dose and LET painting
As mentioned in sec. 2.2.2, the predescribed dose is constant in clinical practice
because no further sub-divison of the tumor tissue is assumed. When deviating from
the standard dose description, e. g. by applying the concept of dose painting to add
additional dose to sub-volumes of the target volume, the total dose given to volumes
outside the target volume is increased as well, because the additional, wanted, dose
always comes along with inevitable dose due to the physical nature of dose deposition
as described in sec. 1.1. In the case of hypoxia, where the OER depends on the
dose-averaged LET of the radiation, one could also think of optimizing the dose-
averaged LET to have sufficiently high values covering hypoxic areas, leaving the
dose constant across the tumor volume, thus reducing the OER and finally the dose
needed to achieve tumor control. However, the LET is closely connected to the
particle’s energy, in such that any given dose distribution has its own dose-averaged
LET distribution, depending on the configuration of irradiation directions. As it
will become clear in the following sections, for dose plans consisting of independently
optimized fields, the dose averaged LET distribution is rather unfavorable, but there
are ways to reshape the dose distribution to also change the dose-averaged LET
distribution.
In addition, using different ions, however, makes it possible to decouple the LET
distribution from the dose distribution to a larger extent. For example, a hypoxic
subvolume of the tumor can be irradiated with heavy particles, such as oxygen ions,
taking advantage of the z2 dependence of the LET, while “filling up” the residual
dose by lighter, lower-LET particles or even photons. The dose and LET painting
concepts are explained in more detail in [46, 47, 48, 30, 31].
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2.3 LET redistribution
The aspects of dose and LET optimization discussed in the previous chapters show
the potential of advancements for future radiotherapy. However, the special treat-
ment of subvolumes, e. g. hypoxic areas of the tumor is only justified if the imaging
of the properties of these areas is possible in a stable, reproducible way. It seems,
however, that apart from the search for an adequate marker for imaging, hypoxic
areas are not always persistent in time, but can present themselves as acute hypoxia
or chronic hypoxia. Acute hypoxia may change over the treatment process, such
that a stable and reproducible imaging of these areas might turn out to be cumber-
some, as the treatment process usually lasts several weeks. Furthermore, the clinical
routine application of these developments require further experimental verification,
clinical trials, and certification by legal authorities, such that the day at which large
amounts of patients benefit from these developments lies in the rather distant future.
However, even with today’s possibilities, a favourable dose-averaged LET can be
achieved by reshaping the dose distributions of the single fields used in particle
therapy. For a pristine Bragg peak, the LET maximum lies just after the rear fall-
off of the dose. As a conventional flat-top spread-out Bragg peak is constructed by
a weighted superposition of pristine Bragg peaks (cf. fig. 1.1) with the largest weight
put on the peak at the rear part, also the dose-averaged LET shows a maximum
right on or just behind the dose fall-off after the SOBP (cf. upper images in fig. 2.4
and fig. 2.5). This is unfavorable because of two reasons: first, the dose-averaged
LET maximum is at the target volume’s border, such that there is no beneficial
effect on hypoxic areas that usually lie deep inside the tumor where the oxygen
supply is diminished because of poor blood perfusion. Second, as there is a relation
between dose-averaged LET and the RBE, the highly effective part of the radiation,
not considering OER, is at the outer border of the target volume as well. Since
the treated volume is already larger than the tumor volume to account for the
uncertainties in the planning process, the high RBE component is simply wasted
with high probability. Moreover, small errors in positioning or small changes in
the patient’s anatomy during the treatment process could make the highly effective
dose area extend even further, possibly exceeding tolerance levels of healthy tissues
nearby.
The natural conclusion is to change the weights and abandon the concept of over-
laying two or more fields with a flat depth-dose distribution. For example, changing
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the depth-dose distributions for a field towards a linearly decreasing dose in the
peak region (dose ramp) still yields a flat depth-dose distribution if the two fields
are overlayed from opposite directions (cf. fig. 2.3). Due to the changed weights of
the pristine Bragg peaks, the dose-averaged LET distribution will also be changed.
The benefits are threefold: First, the dose-averaged LET can be redistributed across
the tumor volume, as will be shown in the next chapter. Thus, the OER in hypoxic
regions can be reduced. Second, the use of dose ramps results in superior dose plans
when concave structures enclosing organs at risk are involved [49]. Furthermore,
using overlapping opposing dose ramps makes the whole treatment plan more robust,
as under- and overdosage areas resulting from imperfect overlay of the single fields
with the target volume can be avoided. And last but not least, dose ramps are
included in treatment planning software that is certified for clinical use already
today, such that, in principle, LET maximization across the tumor volume is possible
right now.
2.3.1 Methods
To demonstrate the beneficial distribution of the dose-averaged LET across the
target volume using dose ramps, the clinical research tool TRiP version 1001c
(cf. sec. 2.2.2), was applied. It is able to calculate the combination of energies,
positions and widths of pencil particle beams needed to achieve a predescribed dose
distribution.
The special method described here is the use of dose ramps to redistribute the
dose-averaged LET. Different from dose painting, no additional dose is put into
sub-regions of the target volume. By changing the parameters shown in fig. 2.3, it is
possible to redistribute the dose-averaged LET to be constant throughout the target
volume or to have a high value in a sub-volume. It is anticipated, however, that
the achieved magnitude of the dose-averaged LET is not high enough to reduce the
OER to values close to 1 using pure proton or carbon ion beams, when comparing
the achieved 3 keV/µm for protons (fig. 2.4) or 75 keV/µm for carbon ions (fig. 2.5)
with fig. 2.2. This becomes even worse with increasing size of the target volume.
Nevertheless, even with the level achieved, the OER begins to change significantly
towards lower values.
As the author is also involved in the Antiproton Cell Experiment (ACE), which aims
at assessing the biological effectiveness of antiproton irradiation, a study involving
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Figure 2.3: Dose ramp and its defining parameters. “posprox” and “posdist” mark
the relative depth position in beam direction inside the target volume along which
the dose ramp is located, “doseprox” and “dosedist” denote the dose levels be-
fore and after the ramp, respectively. In the graph shown, the parameters are
represented by (0.2, 0.8) and (0.8, 0.2) for both fields.
antiprotons is also presented. As TRiP is not able to optimize for antiprotons be-
cause the handling of exotic particles like pions and kaons created in antiproton
annihilation events is not implemented, a detour involving a full Monte-Carlo calcu-
lation using FLUKA version 2011.2b [50, 51] is done. Here, a library of depth-dose
distributions of antiprotons with different energies was generated and the parameters
to achieve flat SOBPs and dose ramps were manually optimized.
To demonstrate the method, a simple 20× 20× 50mm3 target volume embedded in
the center of a 255× 127× 255mm3 water phantom was modeled. Treatment plans
with two opposing fields using protons, carbon ions and antiprotons, respectively,
were generated for the following scenarios:
1. Each field with flat SOBP making up half of the dose.
2. Each field consisting of a dose ramp decreasing from proximal to distal.
As the dose-averaged LET distribution reaches its largest values for carbon ions, a
different redistribution is shown for this particle type to achieve even higher values.
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The redistribution to gain a constant level of dose-averaged LET is shown for protons
and antiprotons.
All plans are optimized for physical dose only to have a common basis of comparsion.
Because the RBE of protons is set to 1.1 for clinical routine throughout the proton
range, the physical and the biological dose is equal except for a constant factor.
Moreover, the RBE assessment for antiprotons is still in progress at the time of
writing this document.
2.3.2 Results
The dose and dose-averaged LET distributions calculated with the treatment plan-
ning tool TRiP for two opposing fields are compared for protons and carbon ions.
For antiprotons, the distributions are calculated with the Monte-Carlo transport
code FLUKA.
Protons
Because of the low charge of protons, their stopping power and, thus, their LET is
low. The dose-ramp method allows for pulling the high dose-averaged LET region
into the target volume, but regarding the OER (cf. fig. 2.2), no significant improve-
ment is expected. Moreover, because of the lacking LET advantage, the dose-ramp
case looks inferior to the standard case in this scenario because of the higher dose
outside the target.
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Figure 2.4: Dose (red) and dose-averaged LET (blue) for protons. Top: flat SOBP,
Bottom: dose ramp. For the sake of clearness, the second, opposing, field is not
drawn. The LETd peak of field 1 is suppressed in the total LETd distribution
because it is weighted with the very low dose of field 1 at the peak position.
Within the target, the average value and the standard deviation from the average
of LETd is 2.90 ± 0.51 keV/µm for the flat SOBP and 3.67 ± 0.17 keV/µm, i. e.,
higher and more homogeneous for the dose ramp, respectively.
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Carbon ions
Because of the z2 dependence of the stopping power, also the LET is increased
significantly. It is, however, not exactly 62=36 times higher as for protons as also
lighter fragments with lower LET contribute to the dose-averaged LET.
In the standard SOBP case, the dose-averaged LET has a rather low value (about
50 keV/µm) in the center, but peaks just at the borders of the target region. Gen-
erally, the hypoxic areas are inside the tumor and not on its edge as the normal
tissue around has good blood perfusion, such that the high LETd is wasted at that
position. For the ramp case, the dose-averaged LET is distributed nearly equally
across the whole volume and reaches a reasonable high value of about 75 keV/µm.
This is still not high enough for a decrease of the OER to values close to 1, but
compared to the standard SOBP, there is already a significant change.
As announced above, the redistribution towards achieving high values of dose-
averaged LET are demonstrated here as well. In the example illustrated in fig. 2.6,
the dose-averaged LET was redistributed to peak at about 118mm depth with a
width of about 10mm. The dose ramp parameters (cf. fig. 2.3) chosen are (posprox=
0.2, dosprox=0.8), (posdist=0.4, dosdist=0.2) for field 1 and (0.6, 0.8), (0.8, 0.2) for
the opposing field 2, respectively. This yields dose-averaged LET values between 100
and 110 keV/µm within 1 cm around the peak, such that a significant OER-effect
can be expected in this area.
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Figure 2.5: Dose (red) and dose-averaged LET (blue) for carbon ions. Top: flat
SOBP. Bottom: dose ramp. Within the target, the average value and the standard
deviation from the average of LETd is 57±11 keV/µm for the flat SOBP and 71.2±
4.3 keV/µm, i. e., higher and more homogeneous for the dose ramp, respectively.
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Figure 2.6: Dose and dose-averaged LET redistribution to peak at about 118mm
depth with a width of about 1.5 cm. Top: construction of the dose distribution.
Bottom: dose-averaged LET distribution. Within the target, the average value
and the standard deviation from the average of LETd is 71± 22 keV/µm.
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Antiprotons
The comparison of proton and antiproton data shows two principal differences: be-
cause antiprotons annihilate at rest, the dose yielded in the Bragg peak is higher
by a factor of 2 compared to protons. This makes the entrance dose for antiprotons
significantly lower as less particles are needed for the same peak dose. However,
charged secondary particles generated in annihilation reactions, especially pions,
have long ranges and account for the smoother distal fall-off and an additional, but
low, ambient dose throughout the volume. The dose-averaged LET for antiprotons
is significantly higher than for protons, especially in the peak region the values are
approximately twice as high, however, for the same dose ramp parameters as in the
proton case, the dose-averaged LET distribution is not as homogeneous in the tar-
get, but shows a plateau in its center. The elevated values outside the target region
are attributed to in-flight annihilation events. Compared to the values of carbon
ions, they are still too low to significantly reduce the OER.
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Figure 2.7: Dose (red) and dose-averaged LET (blue) for antiprotons. Top: flat
SOBP. Bottom: dose ramp. The dose-averaged LET is not constant in this case,
due to the different distribution of LETd for each individual field. Consequently,
to achieve a flat combined LETd, other shapes than ramps are needed. Within the
target, the average value and the standard deviation from the average of LETd is
9.97±0.91 keV/µm for the flat SOBP and 11.14±0.84 keV/µm for the dose ramp,
respectively.
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2.3.3 Discussion
Using dose ramps offers an easy way of redistributing the dose-averaged LET. Due to
the z2 dependence of the stopping power, best results are obtained with carbon ions,
where the achieved values correspond to a decrease of the OER from 2.8 to about
1.8–2.0 (cf. fig. 2.2). Further improvement can be reached for heavier particles like
oxygen, which are already available at HIT for experimental purposes. However,
heavier particles have an elevated biological effectiveness already in the entrance
region, making their exclusive use unfavorable. High enough values reducing the
OER close to one with no deterioation of the overall biological dose distribution are
only reached when more sophisticated methods are applied, like the dose and LET
painting method mentioned earlier in sec. 2.2.3, where only the hypoxic areas are
irradiated with heavy particles, while the residual target is treated with low-LET
radiation. Compared to dose and LET painting, the method presented here could in
principle already be applied in clinical cases today. Furthermore, more complicated
patterns can be realized if the number of fields is increased. In this case, dose ramps
would need to be replaced by some more sophisticated shapes.
Preliminary results of the Antiproton Cell Experiment (ACE) state that the biolog-
ically effective dose ratio (BEDR) of antiprotons compared to protons is 3.75 [52].
Considering the relatively low LET of antiprotons, the enhanced biological effect of
antiprotons seems not to be a direct consequence of their dose-averaged LET, if the
relation LET-RBE in fig. 2.1 is applied. In fact, the damage on cellular components
like the DNA caused by a single particle impact has been observed by the collab-
oration to be more pronounced as for carbon ions in the SOBP [53]. This could
possibly be the result of many single damages clustered in the close vicinity of the
annihilation point.
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the difference?
This chapter deals with microdosimetric measurements. Here, the stochastic nature
of ionizing radiation in microscopic volumes can be revealed, which allows to pro-
vide statements about the radiation quality and its biological effectiveness. Micro-
dosimetry evolved from the need to measure energy depositions by different ionizing
radiation types in tissue within distances of 0.1µm to 1µm, the length scale of chro-
mosomes. This is due to the fact that changes in the DNA are the most prominent
precursors of cell mutations and death, and the fact that different radiation types
showed significant differences in their effectiveness in causing these changes [54].
The main objective of this work was to compare spectra taken in two different
particle therapy scenarios: one represents an actively delivered ion beam which is
scanned across the target volume by magnetic deflection and change of the beam’s
energy at the accelerator level. Consequently, only diagnostic devices are in the beam
path, i. e. the beam is “clean” and consists almost purely of the primary ions when
it impinges the patient. The other scenario resembles a passive system where the
beam has to traverse different materials that change its energy and shape to cover
the tumor. Here, the beam consists of a variety of secondary particles produced
in inelastic events in these materials, possibly containing a significant amount of
neutrons which have an adverse biological effectiveness distribution and also might
be a cause for therapy-induced secondary cancers [55].
The question is if the setup used in this work is sensitive enough to measure changes
between these two scenarios, which could in principle qualify it to also detect sud-
den changes in the beam composition due to accidental introduction of unwanted
material in the beam path.
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3.1 Basics of microdosimetry
3.1.1 Conceptional aspects
Apart from the magnitude of the dose, the spatial pattern and characteristics of ion-
ization events of a radiation type has a considerable influence on its biological effect,
as illustrated in fig. 3.1. The concept of linear energy transfer (LET) already aims
towards relating this pattern to an effect (cf. sec. 2.1.2), but it neglects the stochastic
nature of ionization events. Microdosimetry aims to provide a more fundamental
and general insight. It is defined as “the systematic study and quantification of
the spatial and temporal distribution of absorbed energy in irradiated matter” [56].
Microdosimetry can be further sub-divided into regional microdosimetry, where en-
ergy absorbed from ionizing radiation is evaluated at volumes of certain extensions,
called sites, not regarding the microscopic distribution of energy depositions within
the site. The site concept naturally determines the energy deposited locally by
means of a limited volume, i. e. a geometric cut-off, such that energetic secondary
particles can escape it and deposit their energy elsewhere, while on the contrary,
the LET concept refers to locally deposited energy by introducing a energy cut-off
value Δ as described in sec. 2.1.1.
Most experiments are carried out in the branch of regional microdosimetry. The
other, more theoretical, branch is called structural microdosimetry, where the mi-
croscopic pattern of energy absorption, the so-called inchoate distribution, is used to
estimate the effect of ionizing radiation by combining the inchoate distribution with
the pattern of sensitive structures, also considering migration of energy from the
positions where it has been deposited to the structures. This work will exclusively
be concerned with the experimental branch. The basic quantities presented here, as
well as a more extensive introduction into the field can be found in [56].
The most important basic quantity of microdosimetry is the energy deposit, which
is the energy εi absorbed at a transfer point, e. g. an atom:
εi = Ein − Eout +Q (3.1)
Ein is the energy of the incoming ionizing particle, not including its rest energy;
Eout is the sum of energies of all particles leaving the transfer point, again not
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particle
photon
Figure 3.1: Illustration of different ionization patterns. Top: a particle, e. g. a car-
bon ion, causes many ionizations along its track, with low energies and ranges
of the ejected electrons. The energy is densely deposited around the track. Bot-
tom: a photon interacts with the surrounding matter in a more sparse way due
to the lower interaction cross section. The ejected electrons, created by photoab-
sorption, compton scattering or pair production, have high energies and ranges.
Consequently, little energy is deposited in the surroundings of the photon’s path.
including rest energies. Q is energy either released (Q > 0) or absorbed (Q < 0)
at the transfer point by changes of the rest mass of particles involved, e. g. due
to nuclear reactions or pair production. The transfer point is the position where
the interaction has happened, not regarding quantum mechanical uncertainty with
respect to its location. The process is illustrated in fig. 3.2.
The term “ionizing” is generalized to any form of energy transfer in a single inter-
action, including non-ionizing events. This is owed to the fact that the biological
effect not necessarily is a consequence of ionization, but also of changes of confor-
mation of molecules, e. g. due to excitation. This generalization is accounted for by
introducing a classification of transfer points, in such that significant transfer points
mark significant energy deposits, i. e. deposits above a minimum threshold εi ≥ ω
to be able to cause the change under consideration. The average number NR of
relevant transfer points, where the change under consideration has actually occured,
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incoming particle
Ein = Ep
Ep′
Ee−
Eout = Ep′ + Ee−
outgoing particles
transfer point
Figure 3.2: Illustration of an energy deposit
can therefore be expressed as:
NR =
ˆ εi,max
ω
N(εi)p(εi)dεi, (3.2)
with εi,max is the maximum energy deposit, N(εi)dεi the number of transfer points
in the interval [εi, εi + dεi], and p(εi) the probability that the change is due to the
energy deposit εi.
The number of relevant transfer points gives an estimate for the probability of
radiation effects to occur. However, also the geometrical distribution of the transfer
points becomes important, if the effect is caused by more than one change. This
is especially important for statistically correlated relevant transfer points that are
created along a track of a charged particle.
Microdosimetry uses the concept of the (energy deposition) event, which is the pro-
duction of statistically correlated transfer points, to characterize this correlation. In
regional microdosimetry, the energy deposited in one or more events, ε = ∑i εi, is
the sum of all energy deposits in a delimited volume, called the site, cf. fig. 3.3. It
is common to use ε1 to refer to events that are caused by a single particle and its
secondary particles only.
Because the underlying physical processes are stochastic, ε also is a stochastic quan-
tity.
It is furthermore important to distinguish the energy expended by the incoming
particle at a transfer point from the energy absorbed, as secondary particles pro-
duced at the transfer point may have high enough energies to transport a significant
fraction of the expended energy away, outside the site. This is similar to the cut-off
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Figure 3.3: Illustration of events in a site. If all of the three particles coming from
the left originated from the same primary particle, the situation would be termed
“single event”.
value ∆ which was introduced in the LET concept in sec. 2.1.1, which also limits
the energy considered to transfers below ∆.
The stochatic analogon to the physical dose is the specific energy z, which is defined
as:
z = ε
ρ · V =
ε
m
(3.3)
It is the energy ε absorbed in one or more than one statistically independent events in
a site that has the density ρ and the volume V, i. e. the mass m. Consequently, z has
a probability density distribution, f(z), which is also called frequency distribution,
and whose variance increases, if the volume is decreased. For very small volumes, z
can even be equal to zero, because the volume does not contain any transfer point.
Thus, statements on z or f(z) must include information about the volume V. The
specific energy has the same unit as the physical dose, 1Gy = 1 J kg−1.
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The lineal energy y is a quantity similar to the linear energy transfer:
y = ε1
l¯
(3.4)
It is defined as the energy absorbed in a single event, ε1, along the site’s mean
chord length l¯, which is the average length of randomly oriented chords. In convex
volumes, Cauchy’s theorem yields for the mean chord length l¯ = 4V
S
, where V is
the volume and S the surface of the volume, which gives l¯ = 23 d for spheres, with d
being the diameter of the sphere. The unit is Jm−1, but usually it is expressed in
keV µm−1.
For the following definitions of averages of the specific and lineal energies, it is
convenient to regard ε continuous, even though it is discrete because it is the finite
sum of energy deposits with well-defined, discrete, values.
The frequency average is the first momentum of the frequency distributions, the
dose average is the second momentum of the distributions divided by the first:
yF =
ˆ ∞
0
y f(y) dy; yD =
1
yF
ˆ ∞
0
y2 f(y) dy (3.5)
zF =
ˆ ∞
0
z f1(z) dz; zD =
1
zF
ˆ ∞
0
z2 f1(z) dz (3.6)
f1(z) represents the propability density distribution of z where a single event has
happened, making it independent of the total dose. Consequently, f1(z) is not
defined at z = 0. While zF can be identified with the physical dose, there is no
direct relation between yF and the linear energy transfer as, for a single event, y
and z are only different by a numerical factor in the case of a single event:
z = ε1
m
=
y · 4V
S
m
= 4y
ρS
(3.7)
Measurements are typically represented as function of y.
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3.1.2 Practical aspects
Measuring something small with something big
The prinicpal measurement device is the tissue-equivalent proportional counter which
will be described in more detail in sec. 3.2.1. It is able to measure energy deposi-
tion events in volumes with extensions in the range of micrometers, even though its
physical size is larger, typically in the order of a few centimeters. This is possible
due to Fano’s theorem stating that “in a medium of given composition exposed to
a uniform fluence of primary radiation, the fluence of secondary radiation is also
uniform and independent of the density of the medium as well as the density varia-
tions from point to point” [57]. This allows to replace the microscopic volume with
a certain density by a larger gas volume of equivalent effective density (cf. fig. 3.4),
if the condition expressed in eq. 3.8 is fulfilled.
∆Et
∆Eg
dt
dg
ρt ρg
Figure 3.4: Fano’s theorem (Eq. eq. 3.8, eq. 3.9) allows for replacing the micro-
scopic tissue site (diameter dt, density ρt) by a larger site of lower density (dg and
ρg, respectively), such that the energy loss of a particle ∆Et in the tissue volume
is the same as ∆Eg in the larger equivalent volume.
∆Et =
(
1
ρ
dE
dx
)
t
ρtdt =
(
1
ρ
dE
dx
)
g
ρgdg = ∆Eg (3.8)
ρtdt = ρgdg (3.9)
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The term in brackets is the mass stopping power, the indices t and g represent
tissue and the gas, respectively. dt,g are the diameters of the microscopic and the
gas volume, and ρt,g their densities, respectively. In eq. 3.9, the assumption was made
that the stopping powers of tissue and the gas inside the detector are identical, which
is only true if the atomic composition of the wall of the detector and the gas inside
is the same as for the tissue, which is met as good as possible (see tab. 3.1), but not
exactly. To simulate a certain volume size, the gas density is varied by changing its
pressure pg which can be, assuming ideal gas characteristics, calculated by
pg = p0 · dt
dg
ρt
ρ0
, (3.10)
where the subscript 0 corresponds to the normal conditions of the gas.
Wall effects
The concept of a microdosimetric measurement is based on replacing a microscopi-
cally small volume by a larger volume with a lower density. In typical detectors, the
low density volume is confined by a wall which has a higher density, which causes
distortions of the signals. They are called wall effects and result in a higher energy
deposited in the detector as additional particle tracks traverse the detector. As a
consequence, to avoid these effects, wall-less counters have been designed, where the
solid wall is replaced by a thin mesh of tissue-equivalent material [58].
Three types of wall effects are distinguished and illustrated in fig. 3.5 and fig. 3.6.
In each of the figures, the left picture represents the microscopic site, without any
density change at its outer border. The middle picture shows the situation if the
microscopic tissue volume is replaced by a thin gas, including the size scaling to be
equivalent to the dense scenario, which is resembled by wall-less counters. The right
picture demonstrates the scenario with the detector consisting of a dense wall and
a thin gas.
The delta-ray effect in fig. 3.5 refers to a situation where a primary particle generates
a delta-ray before entering the site. In the case of uniform density of the site and
its surroundings, as it is the case in tissues and in wall-less counters, either the
primary particle or the delta-ray enters the site. However, in the case of walled
counters, it is possible that, due to the dense wall, both the primary particle and its
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Figure 3.5: The delta-ray effect. A primary particle generates a delta-ray before
approaching the site. Left and center: only the delta-ray enters the site because
the density of the surrounding is the same. Right: situation in walled counter,
where the surrounding of the site is denser.
delta-ray enter the site. The effect is most prominent for heavy charged particles,
but the energy contribution of the delta-ray is low compared to the one of the heavy
particle, such that the distortion of the energy-weighted yD is lower that that of yF .
However, both averages are overestimated substantially if the secondary particle is
not a delta-ray, but a heavy charged particle resulting from an inelastic scattering
reaction of the primary particle, which is called V-effect.
The re-entry effect shown in fig. 3.6 is most important for electrons, because of their
curved paths. The scattering in the dense wall could make the electron traverse the
gas volume again, which would not be the case in a medium of uniform density.
Kellerer estimates the re-entry rate of electrons with kinetic energies around 1MeV
is in the order of 20% [59].
Graphical presentation of measurements
The low density of the gas and the proportional counter mode of the detector makes
it very sensitive, being able to detect already a few ionizations. But also very large
energy depositions can be measured, which allows the range of the lineal energy to
span many, typically 5–8, orders of magnitude. This large dynamic range makes a
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Figure 3.6: The re-entry effect.
logarithmic plot along the lineal energy axis necessary. Because
ˆ y2
y1
f(y) dy =
ˆ y2
y1
(y · f(y)) d(ln y) = ln(10)
ˆ y2
y1
(y · f(y)) d(log y), (3.11)
the ordinate is multiplied with y in the semi-log representation.
The area limited by [y1, y2] represents the fraction of events having values of y in
that range. It is common in the community to weight the frequency distribution with
y, making the area under the so-called dose distribution in lineal energy d(y) = y·f(y)
yF
express the fraction of total dose caused by events in the interval. An illustration of
the different representations is given in fig. 3.7.
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3.1.3 Applications
RBE estimation for radiation therapy
Microdosimetry has helped to establish models predicting the RBE for high-LET
radiation, such as fast neutron therapy, boron neutron capture therapy (BNCT) and
heavy ion therapy. For the latter, the microdosimetric kinetic model (MKM) [60,
61, 62, 63] has been developed by Hawkins and others and is successfully applied in
treatment centers in Japan [14, 64]. The model combines elements of theory of dual
radiation action [65], of the lethal-potentially lethal [66] and the repair-misrepair
models [67] to predict the surviving fraction of cells from the dose deposited to
volumes of subcellular size, independently of the radiation type.
It turned out that the dose-mean lineal energy, yD (cf. eq. 3.5), is a good parameter
to link the microdosimetric spectra to RBE values. To account for an decrease of the
RBE for large yD, similarly to the LET-RBE relation described in sec. 2.1.2, a satu-
rated dose mean lineal energy, ysat = y
2
0
y
(1− exp(−(y/y0)2)) with y0 =125 keV µm−1,
was introduced by Kellerer and Rossi, transforming the dose mean lineal energy to:
y∗ =
´∞
0 ysat y f(y) dy´∞
0 y f(y) dy
(3.12)
Together with other model parameters depending on the tissue, a survival curve
can be calculated, and, by comparing it to a reference survival curve, the RBE
can be obtained [14, 68]. Newer extensions also regard the time structure of the
treatment [69] and find a decrease of the RBE of several percent, if the treatment
is prolonged or interrupted.
Radiation protection
Microdosimetric equipment has been in use in the field of radiation protection for
a long time. Here, the biologically equivalent dose is needed to estimate the haz-
ardousness of an unknown mixed radiation field in all areas where ionizing radiation
is involved, e. g. in nuclear power plants, research centers, long-distance flights, but
also in space radiation research, where the radiation exposure of astronauts is as-
sessed.
41
Chapter 3 Microdosimetry: do neutrons make the difference?
The International Commision on Radiation Units and Measurements (ICRU) has
established a framework to calculate the biolgically effective dose by introducing a
weighting factor Q that the physical dose is multiplied with and that depends on
the radiation quality [70]. In particular, Q depends on the lineal energy y, with
a maximum at lineal energies around 100 keVµm−1. The International Commision
on Radiological Protection (ICRP) uses the LET concept to state a relation of the
weighting factor in depenance of the LET, with a similar relation [71].
3.2 Materials and Methods
3.2.1 Detector
For the measurements presented here, a spherical Rossi-type tissue-equivalent pro-
portional counter (TEPC) is used. The original design was developed by Rossi [72],
giving the detector its name. A thorough overview of the design of TEPCs is given
in [58]. It is manufactured by Far West, Inc. and has a physical inner diameter of
1.27 cm (0.5 inch). As the name already suggests, it reaches its tissue equivalency
by manufacturing the 1.27mm (0.05 inch) thick wall from A-150 tissue-equivalent
plastic [73], which is electrically conductive and has a composition similar to mus-
cle tissue as defined by the ICRU, and by being filled with a propane-based gas
mixture of almost the same atomic composition, cf. tab. 3.1. Apart from being as
tissue-equivalent as possible, the gas also must provide a high gain for achieving
good counting statistics. While propane-based gas has better gain properties and
a composition closer to A-150 plastic, methane-based tissue-equivalent gas has an
atomic composition more similar to the one of the ICRU muscle. The detector de-
sign is depicted in fig. 3.8. At a gas pressure of 88.5 hPa, this TEPC simulates a
spherical volume of 2µm of unit density.
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Figure 3.7: Microdosimetric spectra of neutrons from an Americium-Beryllium
source. A: spectrum with linear horizontal axis. Events with lineal energies higher
than about 40 keV/µm can not be seen in this representation. B: the same spec-
trum with logarithmic horizontal axis using the transformation in eq. 3.11. The
area under the curve between two values of y represents the fraction of events,
which lets conclude that e. g. about half of the events have lineal energies lower
than approximately 3 keV/µm. C: instead of the fractional number of events, the
area represents the fraction of dose delivered by events limited by two y values.
Even though about half of the events have lineal energies lower than 3 keV/µm,
about half of the dose is deposited by events with lineal energies larger than about
40 keV/µm. This measurement has been used to calibrate the horizontal axis us-
ing the proton edge feature described in sec. 3.2.4. Therefore, the scaling factor
relating the hardware channel number of the measuring equipment to a lineal en-
ergy y was chosen such that the proton edge (gray area in C, zoomed in D) is at
150 keV/µm.
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Element ICRU muscle A-150 plastic Propane-based TE gas
H 10.1 10.2 10.3
C 11.1 76.8 56.9
N 2.6 3.6 3.5
O 76.2 5.9 29.3
F 1.7
Ca 1.8
Table 3.1: Atomic compositions (%) of muscle tissue as defined by ICRU,
A-150 tissue-equivalent plastic and propane-based tissue-equivalent gas.
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Figure 3.8: Tissue-equivalent proportional counter. The inner wire is encircled
by a helix wire which generates the cylindrically symmetric electric field in the
sphere. Both capacitors have 0.01µF capacity, R1 = 3.9MΩ, R2 = 30MΩ, and
R3 = 6.8MΩ.
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To achieve a uniform electric field, especially at the ends of the inner wire which are
close to the wall, a wire helix around the inner wire confines the high electric field
region close to the wire. This is where the acutal proportional region is located.
550V are applied to the inner wire to collect the electrons from ionization events,
and a voltage divider splits the voltage to the helix and the detector wall such that
the avalanches occur between the helix and the wire and the remaining electric field
between wall and helix is large enough to collect all ions. The power supply needs to
have a very low noise voltage output, as the noise directly couples into the measured
signal. Therefore, a iseg SHQ 224M power supply was used with a measured noise
of less than 2mV.
3.2.2 Read-out electronics
An overview of the read-out electronics setup is given in fig. 3.9.
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Figure 3.9: Electronics setup
45
Chapter 3 Microdosimetry: do neutrons make the difference?
Preamplifier
The signal of the TEPC is a negative charge pulse whose height is proportional to
the energy deposited in a single event in the detector. In order to not couple am-
bient electromagnetic noise into the signal, a low-noise charge-sensitive preamplifier
(Canberra Model 2006 ) is connected to the TEPC with a very short cable to convert
the pulses into exponentially decaying voltage pulses with the height proportional
to the primary ionization signal. The output pulses have positive polarity with a
fast rise-time of less than 20 ns and a decay constant of 50 µs and are split in two,
before they are fed into two spectroscopy amplifiers.
Spectroscopy amplifier
The two spectroscopy amplifiers integrate the preamplifier signals and provide ad-
ditional amplification. Because the primary signal has a wide dynamic range, the
signal from the preamplifier is fed into separate amplifiers having different gains
to guarantee good resolution throughout the range. Three or even more amplifiers
are recommended. In the setup used for the experiments presented in this work,
two ORTEC 572A spectroscopy amplifiers were used with gains set to 10 and 100,
respectively, to measure the high lineal energy events and also to have a good resolu-
tion for the low lineal energy ones. Their output is a quasi-gaussian shaped voltage
pulse with amplitudes up to 10V.
Multi-channel analyzers, data acquisition
The amplified signals are fed into two independent multi-channel analyzers (ORTEC
Aspec 927 ), each having 16384 channels. They convert the pulse height from the
spectroscopy amplifiers into a channel number which is binned in a histogram on
the screen of a connected computer. These histograms can be saved and represent
the raw data for the following analysis.
3.2.3 Data processing
A self-written routine is used to read in the raw data and do the necessary process-
ing to yield the lineal energy spectra in frequency and dose, respectively, and the
46
3.2 Materials and Methods
associated moments of the distributions. The two spectra are merged and the chan-
nel numbers converted into a linear energy scale with conversion factors obtained in
a calibration measurement (cf. sec. 3.2.4). Afterwards, the data is rebinned onto a
logarithmic horizontal axis with the transformation described in sec. 3.1.2. Finally,
the moments of the distribution are calculated and the histograms are displayed and
saved.
3.2.4 Calibration
The raw data as displayed in the data acquisition software is proportional to the
lineal energy, but the proportionality factor has to be determined in a calibration
measurement. There are several methods for calibrating a TEPC, each involving
irradiating the detector with radiation that imparts well known amounts of energy.
The most convenient calibration method for high-LET radiation is to have a small
radioactive 244Cm or 241Am alpha source built into the detector. The geometry of
the emission is known, the energy loss of the particles in the cavity can be calculated,
thus a relationship between channel and lineal energies can be established. However,
this method has systematic uncertainties in the order of 10% because of uncertainties
in the initial kinetic energy (due to the finite source thickness) and unknown details
about the geometrical path of the particles (for more details cf. [74]). Furthermore,
the manufacturer of the TEPC used for the experiments presented here experienced
a supply bottleneck with radioactive sources, thus another calibration procedure was
used.
Neutrons with kinetic energies above several 100 keV, e. g. from an Americium-
Beryllium (AmBe) source, impart energy into the TEPC by recoiling protons which
they create essentially in inelastic collisions with the wall material. These secondary
protons have a broad energy distribution, depending on the kinematics of the col-
lision. However, there is a maximum possible energy a proton can deposit in the
detector. This is the case if it has just enough energy to traverse the gas along
a full diameter, stopping right before the opposite wall. Protons with less energy
naturally deposit less energy, those with higher kinetic energies carry away some
energy that is deposited elsewhere. Hence, there is a sharp drop in the measured
spectrum that is called the proton edge. To stop after traversing 2µm of ICRU mus-
cle medium, a proton needs initially about 150 keV kinetic energy (projected range
looked up in PSTAR [75]), making the proton edge appear at y = 150 keV/µm.
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However, also heavier recoiling nuclei are created and energy and range straggling
of the protons blur the edge, which gives rise to an estimated uncertainty of the
proton edge position of ±10 keV/µm. The setup and measured spectrum is shown
in fig. 3.7 (sub-figures C and D).
3.2.5 Measurement environment at Heidelberg Ion-Beam
Therapy Center (HIT)
General features of the facility
HIT is a clinical facility to provide the entire environment for treating cancer pa-
tients with proton and carbon ion beams. The accelerator section consists of two
independent ion sources, a linear accelerator section, and a synchrotron which is
capable to deliver protons at energies between 48 and 221MeV and and carbon ions
with energies between 89 and 430MeV/u, respectively. The ions are then trans-
ferred to several treatment rooms where they are deflected by a pair of horizontal
and vertical magnets to scan the lateral extensions of the tumor with the beam.
Two of the treatment rooms provide beam exits in a horizontal direction and a third
room is equipped with a gantry that is able to rotate the beam 360° around the
patient. Further degrees of freedom are patient positioning, the choice of the beam
size, and its current. All beam parameters are stored in a hardware library, such
that any possible combination can be requested within one synchrotron cycle. The
measurements presented here were carried out in an additional room, the quality
assurance room, which is technically equivalent to a horziontal treatment room. Be-
cause the standard currents used for patient treatment are rather high to save time
(up to about 1010 particles per second for protons and 108 particles per second for
carbon ions, respectively), even the lowest possible current available in the hardware
library was by far to high to measure single-event spectra. Hence, to avoid pile-up
in the spectra, the beam current was manually reduced by changing the deflection
strength of a magnet in the source section of the accelerator chain. The currents
needed for the experiment were so low such that the signal of the beam monitoring
system which is used to correct for position deviations and to measure the number
of particles delivered during treatment was below threshold. This made it impossi-
ble to record the current pattern during beam extraction, thus ensuring a constant
beam. Because no other detector able to measure the beam intensity was available,
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the current was lowered to the lowest value possible, such that the next lower setting
resulted in no measureable signal at all; still it can not be entirely excluded that
during limited amounts of time, the beam current was too high, producing pile-up
events.
3.2.6 Active and passive beam delivery
As mentioned in the introduction of this chapter, the aim of this study is to asses the
ability of the detector to monitor differences in the spectra of ion beams for passive
and active delivering systems. HIT is an active system by design, as described in
the section above. The only material in the beam is the vaccum exit window, a
set of three ionization chambers sandwiched between two multi-wire proportional
counters used for the treatment control system,1 and an optional ripple filter, which
is used to widen the width of the Bragg peak by inserting a plastic plate with a
thickness of 3mm that is thinned down in a peridodic ridge-like pattern, such that
different parts of the beam traverse a slightly different amount of material, making
them stop at slightly different depths.
Compared to a passive beam delivery system, this is still very little material. The
passive technique most often has a cyclotron accelerating the beam to a fixed energy
that has to be high enough to penetrate about 20–30 cm into tissue to be able to
reach any position in the patient. For target volumes that are located more in front,
the excess beam energy has to be taken away again by degrader material (cf. fig. 3.10)
that is put into the beam path. Some manufacturers of commercially available ther-
apy accelerators introduce an energy selection system that uses magnets to filter
away the secondary particles produced from the reactions in the degrader. How-
ever, additional material of varying thickness is needed to modulate the Bragg peak
position along the beam direction, i. e. to produce a spread-out Bragg peak. This is
usually realized by a spinning wheel with different thicknesses of material mounted
on it. Afterwards, the beam is widened by specially designed scatter devices, be-
fore it is collimated again to the lateral target shape by patient-specific collimators.
Consequently, the beam is always impinging the target volume on its whole lateral
extension at once, contrary to the active case, where a thin beam is scanned over
1It actually turns out that for low extraction energies there is a substantial influence of the tung-
sten wires of the multi-wire proportional counters that are used to verify the beam’s position,
cf. [76]
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the volume. The last element in the beam delivery system is a patient-specific com-
pensator consisting of a plastic block with a specially milled pattern to match the
range of the particles to the shape of the rear part of the target volume. At least
the last three elements mentioned are on the same axis as the patient, such that all
the secondary particles generated in inelastic scatterings with these materials could
potentially reach the patient and deliver unwanted dose. Especially neutrons are
dangerous because of their enhanced biological effect throughout their range.
Synchrotron
Cyclotron
Beam
steering
magnets Comp
Coll
Patient-specific
Sca Mod EF Deg
ICMWPC,
IC
Active beam delivery Passive beam delivery
Patient
Figure 3.10: Active and passive beam delivery. Sizes and distances not to scale.
The half picture left of the patient shows the active beam delivery case, the right
half shows the passive case. Abbreviations along beam direction: Active: MWPC:
multi-wire proportional counter for beam position measurement, IC: ionization
chamber. Passive: Deg: degrader, EF: energy selection system and filter, Mod:
modulator, Sca: scatterer, IC: ionization chamber, Coll: patient-specific collima-
tor, Comp: patient-specific compensator. Further explanations are given in the
text.
3.2.7 Design idea of the experiment
All experiments for the study presented here were carried out at the Heidelberg Ion-
Beam Therapy Center (HIT), which has, as mentioned above, active beam delivery.
Microdosimetric spectra are taken in the plateau region as well as in the Bragg peak
for carbon ions and protons, respectively. The energies of the particles were chosen
such that their range in water is the same for both particle types.
The passive environment is mimicked by choosing the highest possible extraction
energy at the synchrotron and passively degrade the energy by 17.5 cm of PMMA,
such that the beam energy after the degrader is the same as in the active case.
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3.2.8 Setup
The TEPC was placed in a water phantom that is also used for routine quality
assurance measurements. Its walls are made of PMMA and the front window is
thinned down to 5mm. The detector was mounted onto a 3D translation stage with
a positioning accuracy of 0.1mm to be able to measure at different well-defined
depths.
The center of the TEPC in its frontmost placement on the central axis of the phan-
tom was made to conincide with the origin of the room’s coordinate system, the
so-called isocenter, by moving the water phantom. In this configuration, the beam
exit window was at 1.4 meters upstream from the center of the detector, and the
distance to the inner surface of the front window was 3 cm (cf. fig. 3.11). This posi-
tion is the plateau position presented in the results later. The other position was at
9.5 cm behind the front window, the position of the Bragg peak as calculated using
measured range tables that were available at the facility.
Beam exit Water phantom
Beam
TEPC in
plateau
position
TEPC in
peak
position
17.5 cm PMMA
Water3 cm
Figure 3.11: Measurement set-up. The left position of the TEPC is regarded as
the plateau in the results presented later, the shaded position corresponds to
the Bragg peak measurement. To mimick the passive beam delivery scenario, a
17.5 cm thick PMMA block was put in front of the phantom.
The detector was connected to the read-out electronics as described in sec. 3.2.2.
The noise at the output connector of the preamplifier was typically less than 3mV,
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but was critically influenced by external factors. For example, simply changing the
position of the preamplifier increased the noise by several millivolts. Furthermore,
other electrical devices such as the 3D translation stage had to be powered off be-
cause they coupled in substantial noise. Finally, the detector is very susceptible to
microphonic noise, in such an extent that the vibrations of the connected power
supply’s imbalanced fan originally introduced massive oscillations in the preampli-
fier’s output. The power supply was repaired before the actual measurements were
carried out.
As described in sec. 3.2.7, the passive beam delivery environment is mimicked by
inserting 17.5 cm of PMMA in front of the water phantom and increasing the ion
energies to the maximum the accelerator could deliver. For carbon ions, a 3mm rip-
ple filter was used in the Bragg peak position. All beam parameters are summarized
in tab. 3.2.
p,
active
p,
passive
C,
active
C,
passive
Energy (MeV/u) 120.05 221.06 226.05 430.10
FWHM (cm) 1.65 1.26 1.03 0.98
PMMA thickness (cm) 0 17.5 0 17.5
Ripple filter active? no no yes, in
Bragg peak
yes, in
Bragg peak
Table 3.2: Beam parameters
As the lineal energy is defined as the ratio of energy imparted and the mean chord
length, it has to be noted that the mean chord length in the experiment described
here is different from 2/3 d, which is, as mentioned earlier, only true in isotropic
irradiation or, because of symmetry reasons, an irradiation by a broad beam. The
latter condition is not fulfilled here, because the beam shape is gaussian and its
width is narrow, which is needed to precisely deliver dose to the tumor for treatment
purposes. To reduce this influence as much as possible, the widest possible width
(about 1 cm full width at half maximum, depending on particle type and energy,
cf. tab. 3.2) was chosen. Because of limited measurement time, the workaround by
scanning the beam over an area larger than the cross section of the detector, thus
averaging out the beam shape, could not be carried out.
The data acquisition time for each measurement presented here took about 20 min-
utes, such that typically about 50 000 events were recorded.
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3.2.9 Monte-Carlo simulations
To compare the experimental findings with simulated data, the setup was also mod-
eled using the Monte-Carlo code FLUKA version 2011.2b. Because multi-purpose
Monte-Carlo codes like FLUKA use a standard set of parameters that balance the
accuracy of the results with the time needed to complete a simulation, the thresh-
olds for production and transport of secondary particles are by default set too high
to yield reasonable microdosimetric spectra, in particular to correctly account for
effects like the wall effect described in sec. 3.1.2 and the accurate production and
transport of low-energy secondary electrons that are potentially able to travel into
the wall before they are stopped. With the thresholds set too high, electrons in
the sensitive volume could be stopped by the code too early when reaching the
transport threshold energy, even though they would be energetic enough to deposit
a significant amount of their energy in the wall. As a result, the code deposits
all of their residual energy into the sensitive volume, which would bias the results.
Therefore, the thresholds for the ’HADROTHErapy’ set of initial parameters were
lowered manually in regions where they are relevant for the simulated results, i. e. in
the inner parts of the TEPC wall and its sensitive gas volume. Because production
and transport thresholds can be set for each material in FLUKA, the TEPC wall is
realized as onion-shaped structure like proposed in [77] (cf. fig. 3.12), consisting of
three concentric shells, to compromise between accurate results and the significant
increase of computation time needed for low thresholds. The A-150 tissue-equivalent
plastic material is duplicated for each shell, maintaining the atomic composition, but
lowering the production and transport threshold for electrons step by step from the
default value of 100 keV in the outer shell, to 10 keV in the middle shell, and 1 keV
in the innermost shell as well as in the gas inside of the detector. The widths of the
shells were chosen according to the ranges given by the continuous slowing down
approximation (csda) model for electrons [75] in A-150 plastic.
A major benefit of Monte-Carlo simulations is that they generally yield additional
information about the data. In the results presented here, not only the microdosi-
metric spectra are simulated like in the experiment, but also the relative contri-
butions of all particle species involved are displayed. Secondary electrons with a
kinetic energy exceeding an internal threshold are treated as independent particles
in the code. If an event only contains energy contributions by the primary beam
particle and electrons, the electron energy was merged into the energy contribution
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of the primary particle. This is done because the amount of energy carried into the
detector by electrons generated outside the detector by other secondary particles
is estimated to be very small. Remaining electron contributions are regarded as
originating from the other particle species occuring in the detector.
For every scenario, 105 to 106 primary particles have been simulated, such that at
least 105 events were recorded in the detector in every simulation.
1 keV
10 keV
100 keV
Figure 3.12: Onion-like implementation of the TEPC in the Monte-Carlo simula-
tions. The production and transport cut-off values of FLUKA are lowered for each
shell to guarantee as accurate particle transport as possible while maintaining a
reasonable computation time.
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3.3 Results
3.3.1 Measurements
Each plot shows the dose distributions in lineal energy both for the active as well as
the passive scenario. Because the differences in the spectra are too small to be visible
if presented in the standard way (cf. sec. 3.1.2), also the vertical axis is transformed
into logarithmic scale.
Protons
Protons, being singly charged, have a lower stopping power compared to carbon
ions (cf. eq. 1.2). Consequently, the majority of events in the dose distribution in
lineal energy plotted in fig. 3.13 have low lineal energies in the range between 0.4
and 10 keV/µm. The events with lineal energies higher than 10 keV/µm are due to
heavier nuclei that were generated in inelastic scattering events, or pile-up events
which could be due to a momentary too high particle rate due to the inhomogeneous
particle extraction at the synchrotron.
For the plateau, the peak at about 0.6 keV/µm in the upper spectrum of fig. 3.13
matches the stopping power for protons in this energy interval. The stopping power
of protons in the Bragg peak is about 80 keV/µm; events with lineal energies in
this range do not appear in the spectrum in the lower part of fig. 3.13. Due to the
limited time available for the measurements, neither a depth scan of the detector
was carried out to find the Bragg peak position, nor a spread-out Bragg peak was
chosen to irradiate it with. Instead, the detector was placed on a position where
the Bragg peak was estimated from range calculations available at the facility. The
lack of high lineal energy events and the similarity to the plateau spectrum suggests
that the actual measurement position was in front of the Bragg peak. However, as
the aim of the measurement is to reveal possible differences in the spectra due to
additional secondary particles generated in passive delivery systems, it is possible
to conclude that, in the irradiated volume, the difference between the two spectra
is negligibly small. Yet, statistical significance is too low to argue if there is a
significant difference in the events with lineal energies higher than 20 keV/µm. The
frequency and dose mean lineal energies are summarized in tab. 3.3.
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Figure 3.13: Dose distributions in lineal energy for protons. Top: plateau. Bottom:
estimated Bragg peak position.
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Carbon ions
Because of their higher charge, carbon ions have higher a stopping power along their
range than protons. Also here, the peak in the spectra for the plateau case matches
the stopping power of about 16 keV/µm. For the passively degraded case, a clearly
visible, however not substantial (logarithmic scale) difference appears at lineal ener-
gies lower than 10 keV/µm, where a larger fraction of the total dose is delivered by
events with lower lineal energies as compared to the active case. This is due to frag-
mentation, i. e. brake-up of the primary carbon ion beams in the PMMA degrader
in inelastic scattering processes, where secondary particles with lower charge and,
therefore, lineal energies are created.
As the energies of carbon ions were chosen to have the same range as the above
mentioned protons, the Bragg peak position was also likely missed here. This is
substantiated by the fact that the observed maximum in the spectrum of lineal en-
ergy events is at about 40 keV/µm, which is, even though enhanced as compared
to the plateau case, significantly lower than expected for the Bragg peak (several
100 keV/µm). The fragmentation of the primary carbon ions is also visible for the
active case, as the actively delivered ions as well undergo inelastic scattering pro-
cesses with the water. Consequently, the differences between the two spectra are
not as large as in the plateau case.
Similarly to the measurements with protons, despite the difference for lower lineal
energies explained already, there is no large difference between the results for the
different beam delivery scenarios. As in the case for protons, more statistics is
needed to make profound statements about the significance of the differences. The
frequency and dose mean lineal energies are summarized in tab. 3.3.
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Figure 3.14: Dose distributions in lineal energy for carbon ions. Top: plateau.
Bottom: estimated Bragg peak position. The shift of the peak in the spectra is
attributed to inaccuracies of the calculated PMMA width, resulting in a slightly
different initial kinetic energy of the primary ions. In the region in front of the
Bragg peak, where the stopping power increases rapidly, these small differences
result in a shift of the spectrum towards higher lineal energies.
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Particle Position PMMA? yF (keV/µm) yD (keV/µm)
Proton Plateau no 1.2 8.3 (*)
Proton Plateau yes 1.2 2.8
Proton “Bragg peak” no 1.4 3.1
Proton “Bragg peak” yes 1.5 9.2 (**)
Carbon Plateau no 13.9 17.9
Carbon Plateau yes 9.5 16.8
Carbon “Bragg peak” no 28.5 45.6
Carbon “Bragg peak” yes 21.4 50.5
Table 3.3: Frequency (yF ) and dose (yD) mean lineal energies for the measure-
ments. The position “Bragg peak” corresponds to a position in front of the Bragg
peak, as described before. Because of the low statistics, yD is heavily influenced
by outliers, such that the two rightmost peaks in the proton measurements are
responsible for the rather high values in (*) and (**).
3.3.2 Simulations
As mentioned in sec. 3.2.9, the experiment was also carried out in-silico, i. e. in a
Monte-Carlo simulation. Here, the detector could be positioned exactly at Bragg
peak depth. Furthermore, not only the total dose spectrum in lineal energy was cal-
culated, but also the individual contributions of every particle species from protons
up to oxygen ions to gain a deeper insight into the composition of the spectra. For
the plateau cases, the spectra also include the measured data. In tab. 3.4, the mean
values are summarized.
Protons
Like in the experiment, there is not much difference between the active and passive
scenario in the plateau case, cf. fig. 3.15. The events with higher lineal energies
are due to heavier particles generated in inelastic collisions and are slightly more
pronounced in the passive scenario, particularly the contribution of carbon ions. The
spectra for the measured data were scaled down to account for the lack of signal
below the 0.4 keV/µm threshold and are, within their limited statistics, compatible
with the simulation.
Larger differences between the scenarios appear in the Bragg peak (fig. 3.16): the
spectrum for the passive case is broadened both to lower and higher lineal energies
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and the higher lineal energies have a larger amount of contributions of heavier par-
ticles. Consequently, the simulations suggest that there is a difference that can be
seen in the measurements, provided that enough statistics is collected.
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Figure 3.15: Dose distribution in lineal energy for protons in plateau. Top: active
beam delivery. Bottom: passive delivery.
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Figure 3.16: Dose distribution in lineal energy for protons in Bragg peak. Top:
active beam delivery. Bottom: passive delivery.
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Carbon ions
Being compound nuclei, carbon ions are able to lose neutrons and protons in inelas-
tic scattering processes with the traversed material. Consequently, they appear as
different elements if their atomic number has changed. Thus, compared to protons,
the contribution of other particle species to the total spectrum is larger.
In the plateau, the spectrum for the passive case extends both towards lower and
higher lineal energies as in the active scenario, as can be seen in fig. 3.17. Further-
more, the relative contribution of fragments is enhanced. Except for slight deviations
in the peak position and height, the measured spectra agree well with the simulated
ones.
High lineal energies in the Bragg peak are almost exclusively due to the carbon ions,
because of the z2 dependence of stopping power and the lack of even higher charged
particles produced in inelastic processes. However, the shapes of the spectra in the
high y region differ significantly when comparing the active and passive scenario
(cf. fig. 3.18): there is a larger contribution of lineal energies at about 100 keV/µm
in the active case, whereas in the passive case, there are more events with even
higher lineal energies.
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Figure 3.17: Dose distribution in lineal energy for carbon ions in plateau. Top:
active beam delivery. Bottom: passive delivery.
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Figure 3.18: Dose distribution in lineal energy for carbon ions in Bragg peak. Top:
active beam delivery. Bottom: passive delivery.
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3.4 Discussion
Particle Position PMMA? yF (keV/µm) yD (keV/µm)
Proton Plateau no 0.8 3.1
Proton Plateau yes 0.9 99.2 (*)
Proton Bragg peak no 3.8 5.9
Proton Bragg peak yes 2.7 5.4
Carbon Plateau no 15.4 19.0
Carbon Plateau yes 10.9 21.43
Carbon Bragg peak no 68.5 116.3
Carbon Bragg peak yes 46.4 183.6
Table 3.4: Frequency (yF ) and dose (yD) mean lineal energies for the simulations.
As in tab. 3.3, yD in (*) is influenced by the outlier at 700 keV/µm in fig. 3.15,
making its value very high.
3.4 Discussion
The results presented in sec. 3.3.1 were obtained in an experiment that was planned
as a precursor to a more thorough measurement. Unfortunately, the main experi-
ment was cancelled due to a lack of beam time caused by extensive procedures to
install important upgrades at the HIT facility.
Comparing the spectra of the measured distributions indicates no large difference
between the active and passive beam delivery scenario and longer running times
of the experiment would be needed for a final proof of a statistically significant
difference. Due to the restricted measurement time, it was impossible to scan along
the estimated Bragg peak position. This led to a placement of the detector slightly in
front of the Bragg peak. Nevertheless, the potential disadvantage of passive beam
delivery systems, in terms of radiation quality, can not be seen here, and is not
expected to be any more significant, if the measurement had been carried out in the
center of the Bragg peak. However, the simulations strongly suggest to collect more
statistics, such that the differences in the spectra also emerge in the measurements.
Still, the differences are so small that they only appear when plotting the spectra
with a logarithmic vertical axis and it is questionable if they are large enough to
account for a difference in biological effect.
Measurements by Martino et al. [78] and Kase et al. [68] show a good agreement for
the carbon ion plateau measurement. The position in front of the Bragg peak can
not be directly compared to the cited measurements. The Monte-Carlo simulations
for the actively delivered carbon ions agree in their shape, relative contributions of
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fragments, and mean values to those presented in [79], where a different primary
beam energy was simulated.
Further experiments should include measurements outside the primary beam path,
e. g. on the beam axis, but several centimeters behind the Bragg peak, or at lateral
positions. Here, the difference is expected to be more pronounced because of the
absence of the primary beam. However, these measurements are expected to take a
long time, as the fluence of these secondary particles is low compared to the fluence
of the primary ions, and will be very demanding on the beam time schedule.
When measuring in the primary ion-beam path, pile-up is an issue that has to be
addressed by reducing the particle fluence on the detector to about 1000 particles
per second on the detector surface. At HIT, this is well below the usual beam
current range, where high currents are needed for fast treatment times. Because of
the lack of monitoring devices available at HIT for these currents, it is suggested to
use a scintillator at least to inhibit data taking when the momentary particle rate
is too high. It then should be possible to measure the number of extracted primary
particles, thus normalizing the measurements on the scintillator signal instead of
taking the number of events the TEPC has registered.
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4 Conclusion, Outlook
Modern particle radiotherapy increasingly leaves the concept of dose as a quantity
behind and attempts to describe the biological effect using more relevant and mea-
sureable quantities, from biologically effective dose towards cell survival rates. The
treatment planning systems that optimize the beam parameters to obtain a certain
dose distribution can in principle optimize for any quantity, because they only solve
a purely mathematical problem. Thus, it is reasonable to let them optimize for
reaching a given survival level, which is ideally a step function, zero in the target
volume and unity elsewhere. This ultimate goal will never be reached due to the
physical properties of dose deposition as described in previous chapters. However,
models relating biological factors and their dependence on physical quantities and
vice versa, e. g. the OER dependence on the LET, or the RBE dependence on LET,
offers the possibility to approach this ultimate goal further than with today’s dose
planning concepts.
Needless to say that these models require thorough understanding and must be
benchmarked with biological as well as physical experiments. For the latter, more
sophisticated measurement techniques than the standard dose determinations are re-
quested. As pointed out in sec. 2.1.2, there is a relation between LET and biological
effect. Thus, detectors capable of measuring the LET or similar quantities like the
lineal energy are invaluable tools for verifying such a relationship. Apart from pas-
sive detectors like the fluorescent nuclear track detectors or track etched detectors,
active detectors using silicon technology are promising candidates. Silicon diodes
can also be operated as microdosimeters [80] and can be integrated into very small
detectors, and TimePix sensors offer a variety of spectroscopic possibilities [81].
But also the tissue-equivalent proportional counter that was used in this work is,
even though the underlying technology is already 50 years old, still an appropriate
tool to access the radiation quality in terms of lineal energy. Aside from collecting
more statistics, more measurements are proposed, e. g. to assess the microdosimetric
properties of oxygen and helium beams, as well as changes in the spectra, if the beam
has to traverse metal implants or bony structures.
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Nomenclature
CT Computed Tomography. Using mathematical algorithms, the infor-
mation from X-ray photon attenuation for different angles is trans-
formed into a three-dimensional electron density image of the patient.
DNA Deoxyribonucleic acid, the molecule encoding the genetic information
of living organisms
HIT Heidelberg Ion Beam Therapy Center. Patients are treated with
protons and carbon ions. Research is also possible with other ions,
e.g. oxygen.
IMRT Intensity modulated radiotherapy. Not only the shape of each of the
6–8 fields is modulated, but also the photon fluences and thus the
dose, resulting in the possibility to restrict the high-dose volume to
complex-shaped, even to concave-shaped, tumors.
LEM Local Effect Model, relating the very high local doses in close vicinity
to a track of a charged particle to the according surviving fraction at
that dose level, resulting in a RBE when compared to the survival
fraction for the same dose of a reference radiation.
LET Linear energy transfer, also called restricted stopping power. It is a
measure of the ionization density along a single particle track.
MKM Microdosimetric Kinetic Model. A model that relates microdosimet-
ric quantities such as the dose mean lineal energy to the relative
biological effectiveness (RBE).
MRI Magnetic Resonance Imaging. Like CT, it is used for imaging pa-
tients. However, rather than X-ray attenuation, the technique uses
the nuclear magnetic resonance as imaging information. Compared to
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Nomenclature
CT, the contrast in soft tissue is better, which makes MRI a valuable
tool to gain additional information about tumors and their surround-
ings.
OER Oxygen enhancement ratio. The factor of additional dose needed to
kill cells when they are provided with little or no oxygen.
PET Positron emission tomography. A radioactive substance undergoing
β+ decay with short lifetime is attached to a specific molecule, e.g. a
sugar. The two 511 keV photons from the positron annihilation are
detected and their line of origin reconstructed. The accumulation
point of line crossings corresponds to the volume in which the sub-
stance has accumulated. In the case of sugar, it represents an area
of high cellular activity.
RBE Relative biological effectiveness, the ratio of a dose in investigation
and a reference dose, both leading to the same biological effect.
SOBP Spread out Bragg peak. It is a superposition of several Bragg peaks
in longitudinal direction to achieve a constant high dose spread over
a larger volume, e.g. the tumor.
VMAT Volumetric modulated arc therapy. It is a method developed by the
manufacturer Elekta and can be understood as an improved ver-
sion of IMRT. Different from the step-and-shoot-technique in IMRT,
where the fields are applied one after the other, the irradiation is de-
livered while the treatment head is rotating around the patient with
different rotational velocities and continuously moving collimators.
Furthermore, the dose rate is changed along the rotation to achieve
the planned dose distribution, which the manufacturer promotes to
be superior to those gained by IMRT.
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